Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2000) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 11.816 Q1 | 254 | 23 | 57 | 7959 | 1370 | 57 | 25.67 | 346.04 |  |
| 2 | Critical Reviews in Toxicology | journal | 2.041 Q1 | 129 | 12 | 46 | 3053 | 316 | 45 | 6.88 | 254.42 |  |
| 3 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.839 Q1 | 70 | 7 | 41 | 1515 | 253 | 41 | 5.39 | 216.43 |  |
| 4 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.519 Q1 | 82 | 14 | 36 | 2827 | 202 | 36 | 4.12 | 201.93 | |
| 5 | Natural Product Reports | journal | 2.895 Q1 | 211 | 38 | 112 | 6619 | 543 | 112 | 5.00 | 174.18 | |
| 6 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 0.860 Q1 | 99 | 9 | 26 | 1490 | 75 | 26 | 2.88 | 165.56 | |
| 7 | Advances in Pharmacology | journal | 0.938 Q1 | 86 | 29 | 332 | 4343 | 722 | 316 | 4.69 | 149.76 | |
| 8 | Pharmacology and Therapeutics | journal | 3.095 Q1 | 233 | 75 | 171 | 10888 | 1281 | 170 | 6.70 | 145.17 | |
| 9 | Current Drug Targets | journal | 119 | 21 | 0 | 2895 | 0 | 0 | 0.00 | 137.86 |  | |
| 10 | Reviews in Contemporary Pharmacotherapy | journal | 0.229 Q3 | 18 | 17 | 93 | 2155 | 94 | 93 | 1.13 | 126.76 | |
| 11 | Expert Opinion on Therapeutic Targets | journal | 0.146 Q3 | 106 | 44 | 158 | 5137 | 29 | 156 | 0.32 | 116.75 | |
| 12 | Current Drug Metabolism | journal | 122 | 20 | 0 | 2311 | 0 | 0 | 0.00 | 115.55 |  | |
| 13 | Food and Drug Law Journal | journal | 0.279 Q3 | 23 | 41 | 151 | 4578 | 61 | 151 | 0.41 | 111.66 | |
| 14 | Current Medicinal Chemistry | journal | 1.491 Q1 | 202 | 72 | 115 | 7754 | 460 | 109 | 4.52 | 107.69 | |
| 15 | Progress in Medicinal Chemistry | journal | 0.600 Q2 | 38 | 6 | 19 | 646 | 37 | 11 | 2.31 | 107.67 | |
| 16 | Current Pharmaceutical Design | journal | 1.170 Q1 | 183 | 118 | 137 | 11629 | 406 | 126 | 2.91 | 98.55 | |
| 17 | Current Pharmaceutical Biotechnology | journal | 97 | 23 | 0 | 2223 | 0 | 0 | 0.00 | 96.65 | | |
| 18 | Medicinal Research Reviews | journal | 1.338 Q1 | 150 | 22 | 71 | 2038 | 266 | 70 | 3.35 | 92.64 | |
| 19 | Drug Safety | journal | 0.961 Q1 | 140 | 75 | 226 | 6578 | 812 | 219 | 3.38 | 87.71 | |
| 20 | IDrugs : the investigational drugs journal | journal | 0.144 Q3 | 39 | 69 | 241 | 5920 | 63 | 237 | 0.26 | 85.80 | |
| 21 | Advanced Drug Delivery Reviews | journal | 0.967 Q1 | 366 | 98 | 348 | 8251 | 946 | 328 | 2.30 | 84.19 | |
| 22 | Cellular and Molecular Life Sciences | journal | 2.400 Q1 | 261 | 182 | 480 | 14983 | 1747 | 474 | 3.79 | 82.32 |  |
| 23 | Expert Opinion on Emerging Drugs | journal | 0.243 Q3 | 54 | 25 | 63 | 2057 | 49 | 61 | 0.80 | 82.28 | |
| 24 | Clinical Pharmacokinetics | journal | 1.632 Q1 | 184 | 68 | 207 | 5484 | 1126 | 200 | 4.40 | 80.65 | |
| 25 | Toxicology and Industrial Health | journal | 0.556 Q2 | 69 | 34 | 170 | 2662 | 290 | 168 | 1.98 | 78.29 | |
| 26 | Expert Opinion on Pharmacotherapy | journal | 0.119 Q4 | 93 | 89 | 16 | 6820 | 4 | 16 | 0.25 | 76.63 | |
| 27 | Toxin Reviews | journal | 0.336 Q3 | 54 | 12 | 92 | 873 | 73 | 89 | 0.77 | 72.75 | |
| 28 | Annual Report of Shionogi Research Laboratory | journal | 0.235 Q3 | 2 | 2 | 6 | 143 | 2 | 6 | 0.25 | 71.50 |  |
| 29 | Expert Opinion on Investigational Drugs | journal | 0.365 Q2 | 117 | 278 | 449 | 19174 | 510 | 446 | 1.17 | 68.97 | |
| 30 | Drug Metabolism and Personalized Therapy | journal | 0.175 Q3 | 38 | 34 | 48 | 2316 | 25 | 48 | 0.42 | 68.12 | |
| 31 | BioDrugs | journal | 0.187 Q3 | 79 | 81 | 251 | 5271 | 174 | 240 | 0.79 | 65.07 | |
| 32 | CNS Drug Reviews | journal | 0.282 Q3 | 64 | 23 | 96 | 1454 | 84 | 96 | 0.68 | 63.22 | |
| 33 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | | |
| 34 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.126 Q4 | 5 | 19 | 59 | 1135 | 16 | 57 | 0.25 | 59.74 |  |
| 35 | Investigational New Drugs | journal | 0.704 Q1 | 97 | 36 | 130 | 2116 | 264 | 129 | 1.40 | 58.78 | |
| 36 | Drug Resistance Updates | journal | 0.690 Q1 | 132 | 48 | 107 | 2692 | 188 | 99 | 1.76 | 56.08 | |
| 37 | Pharmacogenomics | journal | 100 | 35 | 0 | 1937 | 0 | 0 | 0.00 | 55.34 | | |
| 38 | Prostaglandins and Other Lipid Mediators | journal | 0.428 Q2 | 86 | 58 | 222 | 3166 | 358 | 221 | 1.15 | 54.59 | |
| 39 | Drug Metabolism Reviews | journal | 1.322 Q1 | 108 | 28 | 115 | 1496 | 422 | 115 | 3.18 | 53.43 | |
| 40 | Current Opinion in Drug Discovery and Development | journal | 0.669 Q1 | 85 | 77 | 83 | 3924 | 161 | 78 | 1.94 | 50.96 | |
| 41 | Current Opinion in Molecular Therapeutics | journal | 0.283 Q3 | 67 | 90 | 93 | 4584 | 63 | 87 | 0.68 | 50.93 | |
| 42 | Canadian Journal of Physiology and Pharmacology | journal | 0.647 Q2 | 95 | 131 | 467 | 6574 | 797 | 465 | 1.26 | 50.18 |  |
| 43 | Drugs of the Future | journal | 0.237 Q3 | 46 | 85 | 701 | 4223 | 345 | 701 | 0.99 | 49.68 |  |
| 44 | In Vivo | journal | 0.364 Q2 | 72 | 110 | 260 | 5450 | 283 | 260 | 0.94 | 49.55 |  |
| 45 | Apoptosis : an international journal on programmed cell death | journal | 0.577 Q1 | 128 | 62 | 148 | 3054 | 189 | 148 | 0.92 | 49.26 | |
| 46 | Neurotoxicology and Teratology | journal | 0.707 Q1 | 111 | 84 | 195 | 4130 | 392 | 193 | 1.82 | 49.17 | |
| 47 | Combinatorial Chemistry and High Throughput Screening | journal | 0.885 Q1 | 70 | 48 | 46 | 2336 | 124 | 45 | 2.70 | 48.67 | |
| 48 | Neuropsychopharmacology | journal | 1.965 Q1 | 249 | 153 | 369 | 7399 | 1630 | 336 | 4.47 | 48.36 | |
| 49 | Mutation Research - DNA Repair | journal | 2.461 Q1 | 75 | 75 | 201 | 3594 | 709 | 200 | 3.76 | 47.92 | |
| 50 | Drugs of Today | journal | 0.165 Q3 | 57 | 111 | 298 | 5309 | 146 | 295 | 0.43 | 47.83 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data